• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组织学上切除不完全的直肠神经内分泌肿瘤残留肿瘤的危险因素。

Risk factors for residual tumors in histologically incompletely resected rectal neuroendocrine tumors.

作者信息

Park Jung-Bin, Kim Ga Hee, Kim Minjun, Hong Seung Wook, Hwang Sung Wook, Park Sang Hyoung, Ye Byong Duk, Byeon Jeong-Sik, Myung Seung-Jae, Yang Suk-Kyun, Lim Seok-Byung, Hong Seung-Mo, Yang Dong-Hoon

机构信息

Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.

Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea; Inflammatory Bowel Disease Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea; Digestive Disease Research Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.

出版信息

Dig Liver Dis. 2025 Jul;57(7):1473-1480. doi: 10.1016/j.dld.2025.03.023. Epub 2025 Apr 18.

DOI:10.1016/j.dld.2025.03.023
PMID:40253226
Abstract

BACKGROUND

Rectal neuroendocrine tumors (r-NETs) are often misidentified as polyps, leading to inappropriate endoscopic treatment and incomplete resection.

AIMS

This study investigated the occurrence and risk factors of residual r-NETs following salvage local resection (SLR) after incomplete resection.

METHODS

The medical records of 95 patients who underwent SLR for histologically incompletely resected (R1/Rx-resected) r-NETs referred from other hospitals between January 2020 and August 2023 were analyzed.

RESULTS

The residual r-NET rate was 48.4 % (46/95), varying according to the primary resection method: cold forceps polypectomy (CFP), 70.0 % (21/30); conventional polypectomy or endoscopic mucosal resection (EMR), 41.7 % (25/60); and modified EMR or endoscopic submucosal dissection, 0 % (0/5). The residual r-NET rate was 65.7 % for endoscopically incomplete primary resection versus 0 % for endoscopically complete primary resection. Upon multivariate analysis, endoscopically suspected remnant tumors before SLR (odds ratio [OR], 15.56; 95 % confidence interval [CI], 2.94-82.35, p = 0.002) and the use of CFP for primary resection (OR, 3.60; 95 % CI, 1.02-14.52, p = 0.043) were associated with residual r-NETs after SLR.

CONCLUSION

Salvage resection should be considered for R1/Rx-resected r-NET cases with risk factors for residual tumors to lower the likelihood of recurrence.

摘要

背景

直肠神经内分泌肿瘤(r-NETs)常被误诊为息肉,导致不适当的内镜治疗和切除不完全。

目的

本研究调查了不完全切除后挽救性局部切除(SLR)后残留r-NETs的发生情况及危险因素。

方法

分析了2020年1月至2023年8月间从其他医院转诊来的95例组织学切除不完全(R1/Rx切除)的r-NETs患者接受SLR的病历。

结果

残留r-NETs率为48.4%(46/95),根据初次切除方法而异:冷活检钳息肉切除术(CFP),70.0%(21/30);传统息肉切除术或内镜黏膜切除术(EMR),41.7%(25/60);改良EMR或内镜黏膜下剥离术,0%(0/5)。内镜下初次切除不完全时残留r-NETs率为65.7%,而内镜下初次切除完全时为0%。多因素分析显示,SLR前内镜怀疑有残留肿瘤(比值比[OR],15.56;95%置信区间[CI],2.94-82.35,p = 0.002)以及初次切除使用CFP(OR,3.60;95%CI,1.02-14.52,p = 0.043)与SLR后残留r-NETs相关。

结论

对于有残留肿瘤危险因素的R1/Rx切除的r-NET病例,应考虑挽救性切除以降低复发可能性。

相似文献

1
Risk factors for residual tumors in histologically incompletely resected rectal neuroendocrine tumors.组织学上切除不完全的直肠神经内分泌肿瘤残留肿瘤的危险因素。
Dig Liver Dis. 2025 Jul;57(7):1473-1480. doi: 10.1016/j.dld.2025.03.023. Epub 2025 Apr 18.
2
The role of endoscopic ultrasonography for diagnosis of residual rectal neuroendocrine tumor.内镜超声检查在直肠神经内分泌肿瘤残留诊断中的作用。
Surg Endosc. 2024 Aug;38(8):4260-4267. doi: 10.1007/s00464-024-10963-z. Epub 2024 Jun 12.
3
Efficacy of endoscopic mucosal resection versus endoscopic submucosal dissection for rectal neuroendocrine tumors ≤10mm: a systematic review and meta-analysis.内镜黏膜切除术与内镜黏膜下剥离术治疗直肠神经内分泌肿瘤≤10mm 的疗效比较:系统评价和荟萃分析。
Ann Saudi Med. 2023 May-Jun;43(3):179-195. doi: 10.5144/0256-4947.2023.179. Epub 2023 Jun 1.
4
Endoscopic treatments for rectal neuroendocrine tumors: a systematic review and network meta-analysis.内镜治疗直肠神经内分泌肿瘤:系统评价和网络荟萃分析。
J Gastrointest Surg. 2024 Mar;28(3):301-308. doi: 10.1016/j.gassur.2023.12.016. Epub 2024 Jan 23.
5
Surgical treatment of neuroendocrine tumors in the second portion of the duodenum: a single center experience and systematic review of the literature.十二指肠第二部神经内分泌肿瘤的外科治疗:单中心经验及文献系统综述
Langenbecks Arch Surg. 2017 Sep;402(6):925-933. doi: 10.1007/s00423-016-1537-6. Epub 2016 Dec 3.
6
Clinical outcomes of endoscopic mucosal resection for rectal neuroendocrine tumor.直肠神经内分泌肿瘤内镜黏膜切除术的临床结果
BMC Gastroenterol. 2018 Jun 5;18(1):77. doi: 10.1186/s12876-018-0806-y.
7
Long-Term Clinical Outcomes of Rectal Neuroendocrine Tumors According to the Pathologic Status After Initial Endoscopic Resection: A KASID Multicenter Study.根据初次内镜切除术后病理状态的直肠神经内分泌肿瘤的长期临床结局:一项KASID多中心研究
Am J Gastroenterol. 2016 Sep;111(9):1276-85. doi: 10.1038/ajg.2016.267. Epub 2016 Jul 5.
8
Prognosis of incompletely resected small rectal neuroendocrine tumor using endoscope without additional treatment.内镜下未行追加治疗的不完全切除小型直肠神经内分泌肿瘤的预后。
BMC Gastroenterol. 2022 Jun 9;22(1):293. doi: 10.1186/s12876-022-02365-z.
9
Optimization of endoscopic treatment strategies for R0 resection of rectal neuroendocrine tumors smaller than 10 mm.优化内镜治疗策略,实现直径小于 10 毫米直肠神经内分泌肿瘤的 R0 切除。
Clin Res Hepatol Gastroenterol. 2024 Nov;48(9):102469. doi: 10.1016/j.clinre.2024.102469. Epub 2024 Sep 26.
10
Clinical outcomes after endoscopic resection and the risk of lymph node metastasis in rectal neuroendocrine tumors: a single-center retrospective study.直肠神经内分泌肿瘤内镜切除术后的临床结局和淋巴结转移风险:一项单中心回顾性研究。
Surg Endosc. 2024 Sep;38(9):5178-5186. doi: 10.1007/s00464-024-11088-z. Epub 2024 Jul 23.

引用本文的文献

1
Prognostic Factors in Neuroendocrine Neoplasms of the Rectum.直肠神经内分泌肿瘤的预后因素
Cancers (Basel). 2025 Aug 29;17(17):2841. doi: 10.3390/cancers17172841.